# Effective Treatment of Lung Adenocarcinoma Harboring EGFR-Activating Mutation, T790M, and cis-C797S Triple Mutations by Brigatinib and Cetuximab Combination Therapy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/effective-treatment-of-lung-adenocarcinoma-harboring-egfr-activating-mutation/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yubo Wang,Nong Yang,Yongchang Zhang,Li Li,Rui Han,Mengxiao Zhu,Mingxia Feng,Hengyi Chen,Analyn Lizaso,Qin Tian,Xiaoyan Liu,Yong He |
| Citations | 103 |
| DOI | 10.1016/j.jtho.2020.04.014 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3020050719 |
| PMID | 32353596 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yongchang Zhang](https://scholariq.org/researchers/yongchang-zhang/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Paper topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.